Roy Gerona

6.8k citations
136 papers · 4.6k indexed · 1 hit paper · h-index 35

Impact in

  • Toxicology top 0.02%
    • Forensic Toxicology and Drug Analysis
  • Pharmacology top 0.5%
    • Cannabis and Cannabinoid Research

Papers in

Roy Gerona

131 papers receiving 4.4k citations

Hit Papers

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial 2017 · 393 citations
3932017202620202023100200300

Peers

Roy Gerona
Comparison fields: 5 of 148
  • Toxicology 1.5k
  • Pharmacology 1.2k
  • Health, Toxicology and Mutagenesis 712
  • Developmental Neuroscience 185
  • Emergency Medicine 407
Replace Thomas Kræmer with:
Thomas Kræmer Switzerland
Diana G. Wilkins United States
Bindu D. Paul United States
Jan van Amsterdam Netherlands
A. Schmoldt Germany
Alphonse Poklis United States
Arthur K. Cho United States
Daniel E. Rusyniak United States
Corinne Charlier Belgium
Emilio Russo Italy
Roy Gerona relative to Thomas Kræmer Switzerland Thomas Kræmer's profile →
Citations per field
00.5×3.9×
Thomas Kræmer · 1×
Citations per year

Countries citing papers authored by Roy Gerona

Since Specialization
Citations

This map shows the geographic impact of Roy Gerona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Gerona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Gerona more than expected).

Fields of papers citing papers by Roy Gerona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Gerona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Gerona. The network helps show where Roy Gerona may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Roy Gerona, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roy Gerona Line = papers co-authored together Roy Gerona links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20246
4 20237
5 20231
6 20226
7 202129
8 202132
9 20218
10 202121
11 202029
12 202078
13 202071
14 20203
15 201924
16 2018141
17 201847
18 201734
19 201450
20 200899

About Roy Gerona

Roy Gerona is a scholar working on Toxicology, Pharmacology, Emergency Medicine, Health, Toxicology and Mutagenesis and Occupational Therapy, having authored 136 papers that have together received 4.6k indexed citations. Recurring topics across this work include Forensic Toxicology and Drug Analysis (66 papers), Cannabis and Cannabinoid Research (38 papers), Poisoning and overdose treatments (20 papers), Effects and risks of endocrine disrupting chemicals (18 papers), Psychedelics and Drug Studies (16 papers), Neurotransmitter Receptor Influence on Behavior (15 papers), Alcohol Consumption and Health Effects (11 papers) and Toxic Organic Pollutants Impact (10 papers). The work is most often cited by research in Toxicology (1.5k citations), Pharmacology (1.2k citations), Health, Toxicology and Mutagenesis (712 citations), Developmental Neuroscience (185 citations) and Emergency Medicine (407 citations). Roy Gerona has collaborated with scholars based in United States, Australia and New Zealand. Frequent co-authors include Jordan Trecki, Michael D. Schwartz, Thomas F.J. Martin, Samuel D. Banister, Judith A. Kowalchyk, Patil Armenian, Alan H.B. Wu, Eric Larsen, Axel Adams and Kara L. Lynch. Their work appears in journals such as Clinical Toxicology, Drug Testing and Analysis, ACS Chemical Neuroscience, Journal of Emergency Medicine and Journal of Medical Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026